Evidence map›Paper›PMID 36111293›Full record

ReviewFrontiers in endocrinology2022

The role of pregnane X receptor (PXR) in substance metabolism.

Ye Lv, Yi-Yang Luo, Hui-Wen Ren, Cheng-Jie Li, Zhi-Xin Xiang, Zhi-Lin Luan

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Patchouli alcohol suppressesFrontiers in pharmacology · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. FXR crosstalk with other nuclear receptors.Journal of physiology and biochemistry · 2025
    Review
  17. Review
  18. Physiological Functions and Pathological Roles of PXR.Journal of the Endocrine Society · 2025
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ye LvAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Yi-Yang LuoAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Hui-Wen RenAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Cheng-Jie LiAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Zhi-Xin XiangAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Zhi-Lin LuanAdvanced Institute for Medical Sciences, Dalian Medical University, Dalian, China.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a member of the nuclear receptor (NR) superfamily, pregnane X receptor (PXR; NR1I2) is a ligand-activated transcription factor that plays a crucial role in the metabolism of xenobiotics and endobiotics in mammals. The tissue distribution of PXR is parallel to its function with high expression in the liver and small intestine and moderate expression in the kidney, stomach, skin, and blood-brain barrier, which are organs and tissues in frequent contact with xenobiotics. PXR was first recognized as an exogenous substance receptor regulating metabolizing enzymes and transporters and functioning in detoxification and drug metabolism in the liver. However, further research revealed that PXR acts as an equally important endogenous substance receptor in the metabolism and homeostasis of endogenous substances. In this review, we summarized the functions of PXR in metabolism of different substances such as glucose, lipid, bile acid, vitamin, minerals, and endocrines, and also included insights of the application of PXR ligands (drugs) in specific diseases.

Indexed as

Pregnane X ReceptorReceptors, SteroidXenobioticsAnimalsBile Acids and SaltsGlucoseLigandsLipidsMammalsReceptors, Cytoplasmic and NuclearVitaminsBile Acids and SaltsGlucoseLigandsLipidsPregnane X ReceptorReceptors, Cytoplasmic and NuclearReceptors, SteroidVitaminsXenobioticsbile acidendocrine homeostasisglycometabolismlipid metabolismmetabolismnuclear receptorpregnane X receptor (PXR)vitamin

Identifiers

PMID36111293
PMCPMC9469194
OpenAlexW4291826078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.